Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors

被引:6
作者
Cai, Yibo [1 ]
Liu, Zhuo [1 ]
Jiang, Lai [1 ]
Ma, Dening [1 ]
Zhou, Zhenyuan [1 ]
Ju, Haixing [1 ]
Zhu, Yuping [1 ]
机构
[1] Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp,Univ Chinese Acad Sci, Inst Basic Med & Canc IBMC,Dept Colerectal Surg, Hangzhou, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
关键词
gastroenteropancreatic neuroendocrine tumors; small tumor size; lymph node metastatic patterns; surgical strategy; SEER database; CONSENSUS GUIDELINES UPDATE; MANAGEMENT; CARCINOIDS; SURVIVAL; PROGNOSIS; NEOPLASMS; SURGERY; SIZE;
D O I
10.3389/fendo.2022.871830
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundRegional lymph node metastasis (LNM) is crucial for planning additional lymphadenectomy, and is directly correlated with poor prognosis in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). However, the patterns of LNM for small (<= 20 mm) GEP-NETs remain unclear. This population-based study aimed at evaluating LNM patterns and identifying optimal surgical strategies from the standpoint of lymph node dissemination. MethodsThis retrospective cohort study retrieved data from the Surveillance, Epidemiology, and End Results (SEER) 18 registries database for 17,308 patients diagnosed as having localized well-differentiated GEP-NETs <= 20 mm between January 1, 2004, and December 31, 2017. The patterns of LNM were characterized in 6,622 patients who underwent extended resection for adequate lymph node harvest. ResultsOf 6,622 patients with localized small GEP-NETs in the current study, 2,380 (36%) presented with LNM after regional lymphadenectomy. Nodal involvement was observed in approximately 7.4%, 49.1%, 13.6%, 53.7%, 13.8%, 7.8%, and 15.4% of gastric (g-), small intestinal (si-), appendiceal (a-), colonic (c-), rectal (r-), non-functional pancreatic (nfp-), and functional pancreatic (fp-) NETs <= 20 mm. Patients with younger age, larger tumor size, and muscularis invasion were more likely to present with LNM. Additional lymphadenectomy conferred a significant survival advantage in NETs (<= 10 mm: HR, 0.47; 95% CI, 0.33-0.66; p < 0.001; 11-20 mm: HR, 0.54; 95% CI, 0.34-0.85; p = 0.008) and fp-NETs <= 20 mm (HR, 0.08; 95% CI, 0.02-0.36; p = 0.001), as well as g-NETs (HR, 0.39; 95% CI, 0.16-0.96; p = 0.041) and c-NETs of 11-20 mm (HR, 0.07; 95% CI, 0.01-0.48; p = 0.007). Survival benefits of additional lymphadenectomy were not found in a-NETs, r-NETs, and nfp-NETs with a small size. ConclusionsGiven the increased risk for nodal metastasis, primary tumor resection with regional lymphadenectomy is a potential optimal surgical strategy for si-NETs and fp-NETs <= 20 mm, as well as g-NETs and c-NETs of 11-20 mm. Local resection is an appropriate and reliable surgical approach for a-NETs, r-NETs, and nfp-NETs <= 20 mm.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] NEUROENDOCRINE TUMORS OF THE LUNG WITH SURGICAL RESECTION AND LYMPH NODE DISSECTION IN A TERTIARY THORACIC SURGERY CENTER
    Motas, N.
    Motas, C.
    Davidescu, M.
    Achim, D.
    Rus, O.
    Jianu, E.
    Horvat, T.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2018, 14 (02) : 219 - 226
  • [42] Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection
    Liu, Peng
    Zhang, Xianbin
    Shang, Yuru
    Lu, Lili
    Cao, Fei
    Sun, Min
    Tang, Zhaohui
    Vollmar, Brigitte
    Gong, Peng
    [J]. ONCOTARGET, 2017, 8 (51) : 89245 - 89255
  • [43] Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functiona Gastroenteropancreatic Neuroendocrine Tumors
    Shannon, Adrienne B.
    Straker, Richard J., III
    Fraker, Douglas L.
    Miura, John T.
    Karakousis, Giorgos C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 234 (05) : 900 - 909
  • [44] Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors Analysis From the National Comprehensive Cancer Network Oncology Outcomes Database
    Chan, Hilary
    Zhang, Li
    Choti, Michael A.
    Kulke, Matthew
    Yao, James C.
    Nakakura, Eric K.
    Bloomston, Mark
    Benson, Al B.
    Shah, Manisha H.
    Strosberg, Jonathan R.
    Bergsland, Emily K.
    Van Loon, Katherine
    [J]. PANCREAS, 2021, 50 (04) : 506 - 512
  • [45] Risk factors for lateral pelvic lymph node metastasis in patients with rectal neuroendocrine tumors: a systematic review and meta-analysis
    Chen, Ziyue
    Zhu, Dajian
    [J]. FRONTIERS IN ONCOLOGY, 2025, 15
  • [46] Lymph node dissections and survival in sublobar resection of non-small cell lung cancer ≤ 20 mm
    Shinkichi Takamori
    Takefumi Komiya
    Mototsugu Shimokawa
    Emily Powell
    [J]. General Thoracic and Cardiovascular Surgery, 2023, 71 : 189 - 197
  • [47] Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumors
    Reinhard, Lisa
    Mogl, Martina T.
    Benz, Fabian
    Dukaczewska, Agata
    Butz, Frederike
    Dobrindt, Eva Maria
    Tacke, Frank
    Pratschke, Johann
    Goretzki, Peter E.
    Jann, Henning
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [48] Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors
    Jiang, Sujing
    Zhao, Lihao
    Xie, Congying
    Su, Huafang
    Yan, Ye
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [49] Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumors
    Bertani, Emilio
    Zugni, Fabio
    Radice, Davide
    Spada, Francesca
    Bonomo, Guido
    Romario, Uberto Fumagalli
    Fazio, Nicola
    Funicelli, Luigi
    [J]. UPDATES IN SURGERY, 2022, 74 (05) : 1697 - 1704
  • [50] Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors
    Harimoto, Norifumi
    Araki, Kenichiro
    Hoshino, Kouki
    Muranushi, Ryo
    Hagiwara, Kei
    Ishii, Norihiro
    Tsukagoshi, Mariko
    Igarashi, Takamichi
    Watanabe, Akira
    Kubo, Norio
    Tomonaga, Hiroyasu
    Higuchi, Tetsuya
    Tsushima, Yoshito
    Ikota, Hayato
    Shirabe, Ken
    [J]. WORLD JOURNAL OF SURGERY, 2020, 44 (12) : 4136 - 4141